相关实验视频

Updated: Jun 28, 2025

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

线粒细胞计数可以改善黑色素瘤患者个性化预后吗?

Alessandra Buja¹, Massimo Rugge^2,3, Claudia Cozzolino⁴

¹Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy.

|April 16, 2024

概括

线粒细胞发生率是黑色素瘤患者的显著预后因素,与生存率和死亡率相关. 这一发现支持将其纳入黑色素瘤诊断以实现个性化治疗策略.

科学领域:

在瘤学瘤学.
皮肤病学皮肤病学
病理学病理学病理学

背景情况:

线性速率是黑色素瘤的潜在预后指标.
之前的研究表明,线粒速率和预后不佳之间存在联系.
与其他预后因素的关联需要进一步调查.

研究的目的:

研究黑色素瘤中线粒速率与临床/解剖病理学特征之间的关联.
在对其他因素进行调整后,确定线粒速率的预后值.
确定患者的子组,其中线粒细胞发生率对3年死亡率具有更大的预后意义.

主要方法:

来自威尼托癌症登记处的侵袭性皮肤恶性黑色素瘤病例分析 (2015年,2017年).
卡普兰 - 梅尔曲线是通过线粒体类的整体生存.
考克斯回归模型来评估线粒速率切断的独立预后作用.

主要成果:

线性速率与TNM分期变量 (厚度,,淋巴结状况,转移) 和非TNM因素 (年龄,部位,形态,生长模式,TIL) 相关.
转移率独立地预测了更高的死亡率,特别是在T2黑色素瘤患者中,在调整其他预后因素后.
转移率在各种患者亚组中显示出预后意义.

结论:

线性速率是黑色素瘤的独立预后因素.
建议将线粒速率纳入组织学研究,以改善黑色素瘤预后评估.
线性速率可以为黑色素瘤治疗和监测的个性化医学方法提供信息.

更多相关视频

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma

Published on: March 13, 2013

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...